This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this episode, we sit down with Sara Schweitzer , a passionate recruiter in Stryker’s spine division, whose journey into medical sales and recruiting is anything but ordinary. Sara opens up about her transition from the pharmaceutical world at AbbViewhere, during the pandemic, her work felt more like moving boxes than impacting livesto finding real purpose in helping others land life-changing careers in med tech.
Rhythm Pharmaceuticals drug Imcivree met the body mass index reduction goals of a Phase 3 test in hypothalamic obesity, an acquired form of obesity stemming from dysregulation of the MC4R pathway in the hypothalamus. The engineered peptide drug is already approved for two genetically driven types of obesity. The post Rhythm Pharma Drug Lowers BMI in Rare Form of Obesity Rooted in a Dysregulated Brain Pathway appeared first on MedCity News.
As healthcare professionals, we know firsthand how demanding and rewarding our careers can be. But between long shifts, continuing education, and patient care, theres often little time left to focus on something equally important: your financial future. Thats the benefit of InCrowd surveys. You are able to earn extra income simply by sharing your professional insights all on your own schedule.
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
How do pharma brands cut through the noise and bring the right audiences to their digital doorstep? As digital channels continue to expand, identifying and optimizing the best traffic drivers has become more critical than ever for pharma marketing teams. In this article, well unpack the most effective sources of website traffic in 2025from organic search to paid campaignsand explore how marketing leaders can turn clicks into meaningful engagement.
GSK is licensing an ABL Bio technology yields bispecific antibodies engineered to leverage a certain transmembrane receptor to cross the blood-brain barrier to treat neurodegeneration. GSK is already partnered with Alector, which has monoclonal antibodies in clinical development for Alzheimers disease. The post GSK Grabs Rights to Technology That Gets Drugs Across the Blood-Brain Barrier appeared first on MedCity News.
GSK is licensing an ABL Bio technology yields bispecific antibodies engineered to leverage a certain transmembrane receptor to cross the blood-brain barrier to treat neurodegeneration. GSK is already partnered with Alector, which has monoclonal antibodies in clinical development for Alzheimers disease. The post GSK Grabs Rights to Technology That Gets Drugs Across the Blood-Brain Barrier appeared first on MedCity News.
The Medicines and Healthcare products Regulatory Agency (MHRA) and the University of Liverpool have issued their first analysis of the clinical trial landscape in the UK.The report, published in the British Journal of Clinical Pharmacology demonstrated that currently, UK clinical trials exhibit strong innovation, as well as a concentration of research in certain disease areas, and opportunities for increased representation of certain patient groups.
What if the next patient who needs your medication is already searching onlineand youre not there? In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. Gone are the days when print ads and in-person detailing alone could carry a brand.
Alzheon hoped testing its drug in a genetically defined subgroup of Alzheimers disease patients would succeed, overcoming earlier clinical trial failures. Instead, preliminary results show the pill failed to outdistance a placebo. The post Alzheons Precision Medicine Approach to Resurrect an Alzheimers Drug Fails Pivotal Study appeared first on MedCity News.
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
An innovative air sampling system could improve the efficiency and accuracy of rapid detection for airborne bacteria in the environment, new research suggests. Eraslan-Gltekin et al. developed an air sampling system to collect aerosolised bacterial samples in a liquid medium. By utilising an improved air sampler with loop-mediated isothermal amplification (LAMP) as a rapid nucleic acid amplification method, the proposed method provides a cost-effective and reliable approach to monitoring airborn
Imagine launching a breakthrough therapybut the right people never see it. In a world dominated by digital conversations, failing to master pharma digital marketing is no longer an optionits a risk to market performance. Pharma marketers today must navigate not only consumer expectations but also a tightly regulated environment. The stakes are high, but so are the opportunities.
Solu Therapeutics platform technology, which was licensed from GSK, pairs a small molecule with an antibody to address elusive disease targets. Cancer is Solus initial focus, but the startup is also exploring applications of its platform to immunology. The post Solu Therapeutics Lands $41M for Clinical Test of Novel Antibody Drug for Blood Cancer appeared first on MedCity News.
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.
There is worldwide concern around the use of PFAS. In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.
Can Automating Patient Intake Help Healthcare Providers? Manual patient intake is a burden. Its slow and prone to errors. This can mean long wait times for patients, but for healthcare providers, it can mean missing data, extra costs, and compliance risks. Automation solves the problem by streamlining data capture, improving accuracy, and increasing security.
Poverty significantly impacts the mental and physical health of older adults. Lack of access to care and unaddressed SDOH issues lead to poorly managed chronic conditions, delays in treatment, medication non-adherence, and lower utilization of preventive services. The post The Crisis of Elderly Poverty and Its Health Consequences appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Changing any status quo is challenging, but maintaining the status quo of low patient literacy in healthcare is costly and detrimental to both patients and healthcare organizations. Investing in patient literacy is therefore investing in healthcare itself. The post Oncology Nurses Are Key to Patient Literacy But They Need Support appeared first on MedCity News.
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Five years ago, Michelle Werner received her son’s Duchenne muscular dystrophy diagnosis with fear and desperation. Now, as CEO of Alltrna, she’s finding ways to turn those feelings into a better way of treating rare diseases.
Were stepping into a moment that will undoubtedly redefine care delivery across the medical landscape its one we cant afford to fumble. The post Healthcares Next Chapter: Agentic AI Meets Human-Centric Innovation appeared first on MedCity News.
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
As single use becomes more prevalent, end users are looking for more customization, and regulators are refining their rules, says Todd Andrews of CPC in an interview with Pharmaceutical Technology Group.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
130 
Let's personalize your content